Engineering Guide · Vendor-Neutral

Raman vs NIR Spectroscopy for Bioprocess: Which PAT Analyzer?

Published April 21, 2026 · 11 min read
Raman spectroscopy versus NIR spectroscopy for bioprocess — spectral comparison Laser (785 nm) Culture Detector Sharp peaks — analyte-specific Raman spectroscopy Inelastic scattering · low water signal Glucose, lactate, antibody VS NIR source Culture Detector Broad bands — bulk composition NIR spectroscopy Absorbance overtones · strong water signal Glutamine, ammonium, water content
Figure 1: Raman (left) resolves individual analytes with sharp molecular peaks; NIR (right) measures broader combination bands dominated by water. The two techniques are complementary, not substitutes.
Quick Verdict

Use Raman for in-line monitoring of glucose, lactate, and antibody in mammalian culture — sharp analyte-specific peaks and minimal water interference make it the default PAT choice for fed-batch mAb since 2011. Use NIR when water content, bulk composition, or glutamine/ammonium are the targets, or in downstream UF/DF where the water fraction is controlled. The two are complementary; many advanced facilities deploy both.

Key differences at a glance

Side-by-side comparison

FactorRamanNIR
Measurement principleInelastic (Raman) scattering of laser light from molecular bondsAbsorbance of overtone / combination bands (700-2500 nm)
Peak shapeSharp, analyte-specificBroad, overlapping
Water interferenceVery lowHigh (strong bands at 1450, 1940 nm)
Glucose / lactate accuracyHigher (per Paik et al. 2018)Moderate
Antibody titer prediction±10-15% in 0.5-10 g/L rangeDifficult — low specificity
Glutamine / ammonium accuracyModerateHigher (per Paik et al. 2018)
Measurement time per point30-120 s (signal averaging)1-5 s
Fluorescence sensitivityCan be swamped (solved with 785/1064 nm laser)Not affected
Typical capital cost (per channel)£25,000-£80,000£15,000-£40,000
Dominant use caseUpstream fed-batch / perfusion mAb, AAV, CAR-TUF/DF monitoring, water content, at-line composition

Values reflect typical published specifications and deployment patterns. Vendor datasheets take precedence for specific instrument specs.

Raman spectroscopy explained

Raman spectroscopy measures the frequency shift of scattered laser photons that have exchanged energy with molecular bond vibrations. Each type of bond (C-C, C=O, C-H, amide I, amide III) produces a distinct peak at a characteristic Raman shift in wavenumbers (cm⁻¹). Because the signal depends on polarisability changes during bond stretching, and water is a poor Raman scatterer, aqueous bioprocess media are an ideal sample matrix — analyte peaks are not buried under water absorbance.

How it works

A near-infrared laser (typically 785 nm for mammalian culture, 1064 nm for highly fluorescent samples) illuminates the culture through a probe window or single-use port. The scattered light is collected by the same probe (backscatter geometry), filtered to remove the dominant Rayleigh-scattered (unshifted) component, and dispersed onto a CCD. A chemometric model — typically partial least squares (PLS) regression trained on offline reference measurements — converts the spectrum to analyte concentrations in real time.

When Raman wins

Raman dominates three applications. Upstream mammalian fed-batch — the Paik et al. 2018 parallel comparison in CHO bioreactors showed Raman outperforming NIR for glucose, lactate, and antibody, the three analytes that most commonly drive feed and harvest decisions. High-fluorescence avoidance — 1064 nm Raman excitation eliminates most interference from riboflavin, tyrosine, and tryptophan. Complex matrices — Raman's molecular specificity lets it tease apart analytes in chemically similar mixtures (amino acids, lipids, vitamins) that NIR cannot resolve.

NIR spectroscopy explained

Near-Infrared spectroscopy measures the absorbance of light in the 700-2500 nm range, where molecular bonds containing hydrogen (O-H, N-H, C-H) produce overtone and combination bands. The bands are broad and overlapping — far less chemically specific than Raman — but cheap instruments, fast measurement, and minimal operator skill have made NIR the workhorse of at-line and off-line pharmaceutical analysis for decades. In bioprocess, NIR has a narrower role: it excels where water content itself is the analyte, or where a fast bulk-composition reading is needed.

How it works

A broadband tungsten or LED source illuminates the sample in transmission (fixed path length, typically 1-10 mm) or diffuse reflection (probe against surface). The detector records absorbance as a function of wavelength; a PLS model converts the spectrum to concentrations. NIR requires careful path-length control and benefits from temperature compensation because water absorbance shifts measurably with temperature. For single-use bioreactors, NIR is most commonly deployed via a sampling loop rather than in-situ.

When NIR wins

NIR dominates where water content is the measurement (UF/DF retentate concentration, pharmaceutical moisture QC), where glutamine and ammonium are the key analytes (per the Paik comparison), or where the cost-per-channel advantage matters (high-throughput at-line PAT across many vessels). NIR is also the technology of choice for downstream lyophilisation monitoring and residual moisture analysis. Nirrin's recent UF/DF monitoring platform is a leading example of NIR deployed in a space Raman cannot easily occupy.

Pros and cons

Raman

Advantages

  • Minimal water interference — ideal for aqueous bioprocess
  • Sharp analyte-specific peaks — high chemical specificity
  • Measures glucose, lactate, and antibody simultaneously in one scan
  • Established cGMP pedigree in upstream mAb manufacturing since 2011
  • Single-use bag integration options maturing rapidly

Disadvantages

  • 2-4x the capital cost of NIR
  • Slower measurement — 30-120 seconds per spectrum
  • Fluorescence can swamp the signal at 532/633 nm excitation
  • Calibration models are labour-intensive to build and maintain
  • Weak for glutamine and ammonium measurements

NIR

Advantages

  • Lower capital cost per channel
  • Fast measurement — 1-5 seconds per spectrum
  • Not affected by sample fluorescence
  • Strong performance on glutamine and ammonium
  • Best-in-class for water content (UF/DF, lyophilisation, moisture QC)

Disadvantages

  • Strong water signal dominates spectra in aqueous bioprocess
  • Broad overlapping peaks — lower chemical specificity than Raman
  • Temperature-sensitive — small ΔT shifts water peaks enough to disrupt predictions
  • Difficult for antibody titer prediction
  • Less common as primary PAT in upstream commercial mammalian

Which should you choose?

Pick based on the dominant analyte you need to measure and the phase of the process.

Upstream mAb fed-batch

Glucose feed control, lactate trending, titer monitoring for harvest decision. Aqueous CHO culture at 5-50 million cells/mL. Raman's specificity and water-transparency are decisive.

Choose Raman

Downstream UF/DF

Retentate water content, protein concentration during ultrafiltration, diafiltration endpoint detection. Water content is the analyte, which is exactly where NIR excels.

Choose NIR

Microbial fermentation (E. coli, Pichia)

High biomass, high fluorescence from aromatic amino acids. 1064 nm Raman overcomes fluorescence; NIR struggles with broad spectral signatures from dense biomass.

Choose Raman (1064 nm)

Advanced PAT deployment

Commercial cGMP facility with budget for both platforms. Deploy Raman upstream + NIR downstream; use the combination for continuous-processing digital-twin model training.

Deploy both

Real-world use cases

Four representative deployments and why each team converged on their choice.

CHO mAb fed-batch · 2,000 L
Raman for glucose feed control

Typical setup: Kaiser/Endress+Hauser Raman probe via PG13.5 port, 785 nm laser, 60-second spectra. PLS model predicts glucose (±0.3 g/L) and titer (±10%). Feed pump rate adjusted every 5 minutes from Raman signal.

mAb UF/DF · 50 L TFF
NIR for concentration endpoint

Typical setup: Nirrin tunable NIR probe in TFF retentate loop. Reports protein concentration and water content every 2 seconds. Diafiltration endpoint detected when buffer exchange signature plateaus — no offline sampling.

E. coli inclusion body · 100 L
1064 nm Raman for fluorescence rejection

Typical setup: 1064 nm Raman to avoid tryptophan fluorescence. Monitors acetate accumulation (growth-inhibitory) in real time. NIR was tried first; fluorescence-driven drift required 2x calibration re-fits per week.

Freeze-drying lyophilisation
NIR for moisture endpoint

Typical setup: NIR moisture probe mounted to the vial-sealing station. Detects residual water below 1% threshold before sealing. Raman is not useful here — water content is exactly what NIR is built for.

Need help choosing PAT analytics for your bioprocess?

Answer a few quick questions and get a ranked list of PAT and sensor recommendations for your scale, modality, and analyte — from Raman and NIR through DO, pH, and biomass probes.

Open the Sensor Selection Tool

Cost and lifecycle considerations

The hidden cost of either technology is the calibration model

Instrument capital is only ~40% of total deployment cost. The remaining 60% is PLS model development — offline reference data (HPLC, enzymatic assays) collected across the process design space, regression modelling, validation, and ongoing model maintenance. For a new process, budget 6-12 months of parallel offline sampling before the PAT signal becomes trustworthy for closed-loop control.

A Raman deployment on a single 2,000 L bioreactor typically runs £30-50k for the instrument and probe plus £40-80k for model development (reference assays, chemometrician time, validation batches). NIR is cheaper on hardware (£18-35k) but calibration effort is comparable — the chemometrics work is the same. For advanced deployments using commercial software (e.g. Kaiser's PAT platform, Sartorius BioPAT Spectro), some calibration templates are provided to reduce the model-build burden.

Cost componentRamanNIR
Instrument + probe (per channel)£25,000-£80,000£15,000-£40,000
Model development (6-12 months)£40,000-£80,000£30,000-£70,000
Annual model maintenance£5,000-£15,000£5,000-£15,000
3-year TCO (single channel)£80,000-£190,000£60,000-£155,000

Vendor landscape

Major vendors in each camp, with one-line positioning notes.

Raman bioprocess vendors

NIR bioprocess vendors

Frequently asked questions

What is the difference between Raman and NIR spectroscopy for bioprocess?
Raman measures inelastic light scattering from molecular bond vibrations, producing sharp peaks unique to each analyte (glucose, lactate, antibody, amino acids). Near-Infrared (NIR) measures absorbance of overtone and combination bands from O-H, N-H, and C-H bonds, producing broader overlapping peaks. The practical consequence: Raman is better for concentration-specific readings of individual analytes in aqueous culture; NIR is better for bulk compositional analysis, water content, and situations where fluorescence would interfere with Raman.
Which is better for glucose monitoring in bioreactors?
Raman is better for in-line glucose monitoring in mammalian cell culture. A widely-cited parallel comparison study in CHO bioreactors (Paik et al. 2018) found Raman gave more accurate glucose, lactate, and antibody predictions than NIR, while NIR was better for glutamine and ammonium. For fed-batch CHO where glucose feed control is the primary use case, Raman is the default PAT choice and has been deployed in commercial cGMP mAb manufacturing since roughly 2011.
Can Raman measure antibody concentration in a bioreactor?
Yes — Raman can measure antibody titer in-line once a calibration model is built against offline HPLC-protein-A reference data. Typical commercial deployments achieve ±10-15% accuracy for titer in the 0.5-10 g/L range. This is one of Raman's key advantages over NIR: antibody has distinct Raman peaks (amide I, amide III) that NIR cannot resolve from media components. Titer monitoring via Raman supports real-time harvest decisions and deviation detection.
Why is Raman preferred for aqueous bioprocess monitoring?
Water has a very weak Raman signal but a very strong NIR signal. In a bioreactor where the medium is >95% water, this means NIR spectra are dominated by water absorbance, compressing the signal range available to detect trace analytes. Raman spectra are essentially unaffected by water, leaving the full dynamic range to measure analytes of interest. This is the single biggest reason Raman has become the first-choice PAT for upstream mammalian cell culture.
What are the disadvantages of Raman spectroscopy?
Three main disadvantages. First, fluorescence interference — some media components (riboflavin, aromatic amino acids) fluoresce and swamp the Raman signal; this is usually solved with 785 nm or 1064 nm excitation instead of 532 nm. Second, slower measurement — a high-quality Raman spectrum typically requires 30-120 seconds of signal averaging vs 1-5 seconds for NIR. Third, higher cost — Raman instruments are typically £25,000-£80,000 per channel vs £15,000-£40,000 for NIR.
Does water interfere with NIR measurements in bioreactors?
Yes — water has strong, broad NIR absorbance peaks around 1450 nm and 1940 nm that dominate the spectrum in aqueous culture. This is not fatal (NIR still works in bioprocess) but means calibration models must be carefully trained on data at expected water concentrations, and small temperature changes can shift water peaks enough to disrupt predictions. NIR is more robust in low-water applications like UF/DF retentate monitoring where the water fraction is already controlled.
What can Raman not detect in a bioprocess?
Raman struggles with analytes that are very dilute (typically below ~0.1 g/L for mammalian culture components), highly fluorescent, or chemically similar to other dominant species. Ammonium and glutamine — both important for CHO metabolism — are difficult for Raman and are better measured by NIR. Ionic species without strong Raman-active bonds (Na+, K+, Cl-) are essentially invisible. For these analytes an ion-selective electrode or dedicated at-line bioanalyzer is usually the better solution.
Are Raman and NIR compatible with single-use bioreactors?
Both can be deployed on single-use bioreactors via pre-integrated sterile windows or bag-mounted probe adapters, but Raman has seen more SU adoption. Major bag vendors (Sartorius Biostat STR, Thermo HyPerforma) offer pre-integrated Raman windows for in-line monitoring. NIR is more commonly used off-gas or for ex-situ measurement via a sampling loop. If SU deployment is a hard requirement, check your bag vendor's current portfolio — it changes yearly.

Resources and references